Format

Send to

Choose Destination
Actas Urol Esp. 2012 Oct;36(9):521-6. Epub 2011 Dec 23.

[Incidence, prevalence and mortality of kidney cancer in Spain: estimates and projections for the 1998-2022 period].

[Article in Spanish]

Author information

1
Departamento de Microbiología, Medicina Preventiva y Salud Pública, Universidad de Zaragoza, España. dysouz@yahoo.com.br

Abstract

OBJECTIVE:

To estimate kidney cancer incidence and prevalence in Spain, based on mortality and survival data from the period 1998-2007, and to provide projections of incidence, prevalence and mortality until the year 2022.

MATERIAL AND METHODS:

All-cause and kidney-cancer mortality rates were obtained from the National Statistics Institute and survival data were obtained from the EUROCARE study. Estimations were carried out using the MIAMOD program. The Joinpoint program was used to quantify the expected annual change in the projections.

RESULTS:

An increase in the incidence rate is expected in men from, this going from 11.92 (Adjusted Rate - AR=8.66) per 100,000 inhabitants/year to 15.7 (AR=9.55). Prevalence would increase from 72.84 (AR=51.62) to 94.47 (AR=59.57), and mortality would increase from 5.77 (AR=7.29) to 7.29 (AR=4.56). The incidence rate in women would increase from 5.56 (AR=3.86) to 26.77 (AR=16.4). Prevalence would increase from 24.6 (AR=17.28) to 133.69 (81.37), and for mortality, the expected increase would be from 2.46 (AR=1.54) to 11.65 (AR=6.56) cases per 100.000 inhabitants/year.

CONCLUSION:

The projections indicate that kidney cancer in Spain follows an increasing trend in incidence, mortality and prevalence. This needs to be considered in order to plan more effective prevention and treatment measures.

PMID:
22196967
DOI:
10.1016/j.acuro.2011.09.003
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center